Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3
The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL30104046 | 1.00 | SLC22A1 (0.52) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| Tetrabuthylammonium SCHEMBL2398988 | 0.98 | SLC22A1 (0.50) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| Tetrabuthylammonium SCHEMBL2398990 | 0.98 | SLC22A1 (0.50) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| L-Lactic Acid SCHEMBL9630451 | 0.96 | SLC22A1 (0.52) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| L-Lactic Acid SCHEMBL29256387 | 0.94 | SLC22A1 (0.54) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| Tetrabuthylammonium SCHEMBL1691312 | 0.89 | SLC22A1 (0.55) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| Tetrabuthylammonium SCHEMBL107578 | 0.87 | SLC22A1 (0.52) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| Tetrabuthylammonium SCHEMBL5874496 | 0.87 | SLC22A1 (0.52) | SLC22A1CA1SLC22A2CA2ALDH1A1 | |
| Tetrapropylammonium SCHEMBL5574321 | 0.86 | SLC22A1 (0.48) | SLC22A1CA1CA2CYP3A4TSHR | |
| Tetrabuthylammonium SCHEMBL31025702 | 0.85 | SLC22A1 (0.50) | SLC22A1CA1SLC22A2CA2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 896 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250314970-A1 | OVERCOAT COMPOSITION AND PATTERNING METHODS | TOKYO ELECTRON LTD (JP) | 2025-10-09 | — | — | US | claimed |
| CN-118453443-A | Use of vitamin C lactate and analogues thereof in preparation of skin tissue products and related products | 长春圣博玛生物材料有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-117658802-A | Method for preparing lactate by catalyzing alcoholysis of polylactic acid by ionic liquid | 中国科学院化学研究所 | 2024-03-08 | — | — | CN | claimed |
| CN-117658794-A | Method for preparing lactic acid by catalyzing polylactic acid hydrolysis through ionic liquid | 中国科学院化学研究所 | 2024-03-08 | — | — | CN | claimed |
| CN-117623968-A | Method for preparing N-substituted lactamide by catalyzing polylactic acid aminolysis with ionic liquid | 中国科学院化学研究所 | 2024-03-01 | — | — | CN | claimed |
| CN-115951561-B | Chemical amplification type positive I-line photoresist and preparation and use methods thereof | 徐州博康信息化学品有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117234034-A | Photoresist and preparation and use methods thereof | 江西兆驰半导体有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-115951561-A | Chemically amplified positive I-line photoresist and preparation and use methods thereof | 徐州博康信息化学品有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-1234047-C | Chemical amplification light resistance agent compsn. | AMERICAN EVERBRIGHT CORP (US) | 2005-12-28 | — | — | CN | claimed |
| CN-1696829-A | Chemically Amplified Photoresist Composition | YONGGUANG CHEMICAL IND CO LTD (CN) | 2005-11-16 | — | — | CN | claimed |
| US-6878504-B2 | Chemically-amplified resist compositions | EVERLIGHT USA, INC. (US) | 2005-04-12 | — | — | US | claimed |
| US-20040241569-A1 | Chemically-amplified resist compositions | EVERLIGHT USA, INC. | 2004-12-02 | — | — | US | claimed |
| CN-1538241-A | Chemically Amplified Photoresist Composition | 台湾永光化学工业股份有限公司 | 2004-10-20 | — | — | CN | claimed |
| US-6703178-B2 | COMPRISES A POLYMER CONTAINING A NOVEL LACTONE ALICYCLIC UNIT; WELL-BALANCED OUTCOME OF ETCHING RESISTANCE AND SUBSTRATE ADHESION | EVERLIGHT USA, INC. | 2004-03-09 | — | — | US | claimed |
| CN-1462909-A | Chemical amplification light resistance agent compsn. | AMERICAN EVERBRIGHT CORP (US) | 2003-12-24 | — | — | CN | claimed |
| US-20030232270-A1 | CHEMICAL AMPLIFIED PHOTORESIST COMPOSITIONS | EVERLIGHT USA, INC. (US) | 2003-12-18 | — | — | US | claimed |
| US-12607933-B2 | Polymer compositions having photoacid generators and photoresists | DUPONT ELECTRONICS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-12547072-B2 | Self-aligned build-up processing | GEMINATIO, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| EP-0783136-A2 | Chemically amplified positive photoresists | Shipley Company LLC (US) | 1997-07-09 | — | — | EP | disclosed |
| US-5576459-A | Quaternary nitrogen or phosphorus chirates | SACHEM, INC. (US) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12547072-B2 | Self-aligned build-up processing | MYBBP1A, SMURF1, MYB | SLC22A1 4459/4885CA1 1959/4885SLC22A2 4576/4885 |
| US-12607933-B2 | Polymer compositions having photoacid generators and photoresists | PFAS, AFF1, HBG1 | SLC22A1 2619/4885CA1 2237/4885SLC22A2 2884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.